A Florida-based online seller has recalled two male sexual enhancement supplements sold nationwide for nearly three years after federal testing found dangerously high levels of an ingredient linked to seizures, heart attacks and reported deaths. SUPPLX.com recalled all lots of Branch Manager for Men and Business Pill, both sold in boxes of 24 capsules through the company's website between September 16, 2023 and June 11, 2026.
The recall, announced September 3, 2026, came nearly three months after the Food and Drug Administration first warned consumers in June not to purchase or use the two products because of hidden yohimbine, according to the FDA. As the Miami Herald reports, the agency's recall notice found dangerously high levels of yohimbine in the pills, an alkaloid derived from the bark of the yohimbe tree that is not typically used in over-the-counter supplements.
Yohimbine was once a prescription treatment for erectile dysfunction, but U.S. drugmakers have largely abandoned it in favor of safer options like sildenafil and tadalafil, per the FDA. High doses can trigger severe gastrointestinal distress, nausea, vomiting, diarrhea and stomach pain, the Herald's report notes, along with anxiety, insomnia, mania, psychosis in schizophrenic patients, drowsiness, disorientation, tremors and seizures. More alarming still, the FDA says yohimbine can cause severe hypertension, tachycardia, possible cardiac arrhythmia and heart attacks — and that severe overdoses have caused reported deaths.
A Recall That Followed Months of Federal Warnings
The company is based in Grant-Valkaria, a rural Brevard County municipality incorporated in 2006 that had just 4,509 residents at the time of the 2020 U.S. Census. That small-town address belies the national reach of the sales: the pills were distributed online in single-capsule blister cards and 24-count retail boxes, with lot and expiration information printed on the back of each card, according to FreshRecall.
Consumers who bought the products can request a refund from SUPPLX.com, per the Herald's report, and the company recommends disposing of any remaining pills. Anyone with recall questions can call 321-341-9501 or email [email protected]. People who experienced medical problems after taking the pills should consult a medical professional and report the issue to the FDA through its MedWatch program.
Why Hidden Doses Keep Slipping Through
The gap between the FDA's June warning and September's formal recall reflects a structural feature of supplement regulation, not a delay unique to this case. Under the Dietary Supplement Health and Education Act of 1994, dietary supplements are classified as foods rather than pharmaceutical drugs, meaning the FDA does not evaluate or approve them for safety and efficacy before they reach store shelves or online carts. Enforcement instead depends on after-the-fact lab testing and public notifications like the one issued in June.
That regulatory blind spot appears to be common. A study of over-the-counter yohimbine products found actual doses ranging from 0 mg to 12.9 mg per serving — sometimes exceeding prescription strength — while only 22% of products accurately declared the ingredient amount on their labels, according to Examine.com. Health officials also warn that high yohimbine doses become more dangerous when combined with monoamine oxidase inhibitors, antidepressants, ADHD medications, or stimulants such as caffeine and ephedra.
Part of a Broader Pattern in Sexual Enhancement Products
The FDA's Health Fraud Product Database now holds more than 1,000 public notices about adulterated or misbranded over-the-counter products, with sexual enhancement and weight-loss supplements ranking as the two most frequently flagged categories. Federal toxicologists reported in August 2026 that testing found dangerously high yohimbine concentrations combined with hidden tadalafil and flibanserin in a separate product, WAP Sensual Enhancement, according to Medical Toxicology.
The SUPPLX.com case also echoes a Bay Area recall from earlier this year. In March 2026, novelty retailer Gear Isle issued a nationwide voluntary recall of two lines of sex chocolates hiding Viagra after FDA testing detected undisclosed sildenafil and tadalafil. Two nationwide recalls within months of each other underscore how frequently undeclared active ingredients turn up in sexual health products sold directly to consumers online.
Key questions remain unresolved: it is unclear how many units SUPPLX.com sold nationwide during the nearly three years the products were on the market, and whether any formal adverse event reports submitted to the FDA's MedWatch program have been tied directly to these specific lots.
